Zobrazeno 1 - 10
of 140
pro vyhledávání: '"EZIO ZANON"'
Publikováno v:
International Journal of Translational Medicine, Vol 4, Iss 2, Pp 342-353 (2024)
Hemostasis disorders require particular attention in dental treatment. Dental implants are a very widespread and valid method for total rehabilitation. Flapless dental implant surgery is a minimally invasive treatment that allows the implants to be p
Externí odkaz:
https://doaj.org/article/922235bb72ff48478f2cf021ac9274e6
Autor:
Augusto B. Federici MD, Rita Carlotta Santoro MD, Cristina Santoro MD, Lisa Pieri MD, Roberto Mario Santi MD, Giovanni Barillari MD, Alessandra Borchiellini MD, Alberto Tosetto MD, Ezio Zanon MD, Raimondo De Cristofaro MD, Esther Mairal MD, Roser Mir PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 30 (2024)
Plasma-derived von Willebrand factor-containing factor VIII concentrates (pd-VWF/FVIII-C) are the mainstay of treatment in von Willebrand disease (VWD). Real-world data on efficacy and safety of these pd-VWF/FVIII-C are required. To retrospectively e
Externí odkaz:
https://doaj.org/article/4afed7a9b43643528a9fed511a516d6e
Autor:
Roberto Mario Santi, Annamaria Fulghesu, Ezio Zanon, Erica De Candia, Elvira Grandone, Giancarlo Di Renzo, Claudia Succu, Valentina Tosto, Vincenzina Bruni, Paolo Gresele
Publikováno v:
Bleeding, Thrombosis and Vascular Biology, Vol 3, Iss 1 (2024)
During menarche and adolescence, abnormal uterine bleeding (AUB) may serve as a crucial indicator of a hidden bleeding disorder. When a young woman is suspected of having a bleeding disorder, the obstetrician-gynecologist should collaborate with a he
Externí odkaz:
https://doaj.org/article/22fe84ca7bd3433596f98e0e0156fb12
Autor:
Ezio Zanon
Publikováno v:
Journal of Cancer Rehabilitation, Vol 6, Iss 4, Pp 170-173 (2023)
Background Patients with congenital bleeding disorders require more frequent monitoring and careful management of treatments to avoid bleeding complications. In this context, an attempt is made to investigate the literature regarding rehabilitating
Externí odkaz:
https://doaj.org/article/8ff077f478dd421b9c2688d4e0becd15
Autor:
Massimo Morfini, Jacopo Agnelli Giacchiello, Erminia Baldacci, Christian Carulli, Giancarlo Castaman, Anna Chiara Giuffrida, Giuseppe Malcangi, Angiola Rocino, Sergio Siragusa, Ezio Zanon
Publikováno v:
Hematology Reports, Vol 15, Iss 2, Pp 384-397 (2023)
The Medical Directors of nine Italian Hemophilia Centers reviewed and discussed the key issues concerning the replacement therapy of hemophilia patients during a one-day consensus conference held in Rome one year ago. Particular attention was paid to
Externí odkaz:
https://doaj.org/article/d24dcae5a7a04163aca7e5a8789dc405
Autor:
Ippazio Cosimo Antonazzo, Paolo Angelo Cortesi, Ezio Zanon, Samantha Pasca, Massimo Morfini, Cristina Santoro, Raimondo De Cristofaro, Giovanni Di Minno, Paolo Cozzolino, Lorenzo Giovanni Mantovani
Publikováno v:
Medicina, Vol 60, Iss 1, p 34 (2023)
Background and Objectives: This study aimed to assess the effectiveness and costs associated with pharmacokinetics-driven (PK) prophylaxis based on the myPKFiT® device in patients affected by hemophilia A (HA) in Italy. Materials and Methods: An obs
Externí odkaz:
https://doaj.org/article/e55fef36b5b948c8b0130db8da8a903b
Autor:
Mario Schiavoni, CARLO PRUNETI, SARA GUIDOTTI, ALESSANDRA MOSCATELLO, FRANCESCA GIORDANO, ANTONELLA COLUCCIA, RITA CARLOTTA SANTORO, MARIA FRANCESCA MANSUETO, EZIO ZANON, RENATO MARINO, ISABELLA CANTORI, RAIMONDO DE CRISTOFARO
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 15, Iss 1 (2023)
Background: The health-related quality of life (HRQoL) of people with hemophilia (PWH) is an important issue, especially considering people suffering from chronic diseases beyond hemophilia. The principal aim of this study was to investigate the pres
Externí odkaz:
https://doaj.org/article/cca33725b0ef44bba1ab655be716aa53
Autor:
Ezio Zanon
Publikováno v:
Pharmaceuticals, Vol 16, Iss 9, p 1195 (2023)
Hemophilia A is characterized by a deficiency of clotting factor VIII (FVIII) requiring lifelong prophylactic treatment, typically with recombinant FVIII. In recent years, drugs with extended half-lives have become available, including damoctocog alf
Externí odkaz:
https://doaj.org/article/21a36dffc3224cfdb535f7854fbd44f6
Autor:
Samantha Pasca, Cristina Santoro, Chiara Ambaglio, Marisanta Napolitano, Marta Milan, Letizia Natali, Silvia Nannizzi, Filippo Mori, Paolo Simioni, Ezio Zanon
Publikováno v:
Bleeding, Thrombosis and Vascular Biology, Vol 1, Iss 2 (2022)
Defining the bleeding risk in patients with FVII-deficiency is not easy. Aim of this study is to define correlation and differences between three different scores and the thrombin generation assay (TGA) in correctly evaluating the hemorrhagic phenoty
Externí odkaz:
https://doaj.org/article/fa0269594fa440cb8644f297fb01d33e
Autor:
Ezio Zanon
Publikováno v:
Diagnostics, Vol 13, Iss 3, p 420 (2023)
Acquired haemophilia A (AHA) is a rare bleeding disorder caused by inhibitory autoantibodies against coagulation factor VIII (FVIII). AHA is a disease that most commonly affects the elderly but has also been observed in children and in the postpartum
Externí odkaz:
https://doaj.org/article/836581da88f74c899f75a219592fbd28